MyCelx Technologies Corporation — Director's Dealing 2026

Feb 16, 2026

National Storage Mechanism | Additional information

RNS Number : 1807T

MyCelx Technologies Corporation

16 February 2026

16 February 2026

MYCELX Technologies Corporation

("MYCELX" or the "Company" (AIM: MYX)

Director Dealing

The Company announces that it was notified on 13 February 2026 by Gareth Kaminski-Cook, Non-executive Chairman of the Board of Directors of the Company, that:

-     on 11 February 2026, he purchased 2,350 common shares in the Company of US$0.025 each ("Common Shares"), at a price of £0.47 per Common Share; and

-     on 12 February 2026, he purchased 2,100 common shares in the Company of US$0.025 each ("Common Shares"), at a price of £0.46 per Common Share.

Following these transactions, Mr. Kaminski-Cook holds 4,450 Common Shares representing 0.02 per cent of the total issued capital of the Company.

For further information please contact:

MYCELX Technologies Corporation Connie Mixon, CEO Kim Slayton, CFO	Tel: +1 888 306 6843
Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker) Giles Balleny /Callum Davidson/Elysia Bough (Corporate Finance) Harriet Ward (Corporate Broking) Jasper Berry / Michael Johnson (Sales)	Tel: +44 20 7220 0500

Notification of transactions of persons discharging managerial responsibility or connected persons

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Gareth Kaminski-Cook

2

Reason for the notification

a)

Position/status

Non-Executive Chairman

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

MYCELX Technologies Corporation

b)

LEI

213800UJZINIK2VD1G48

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Common shares of US$0.025

ISIN: US62847T2024

b)

Nature of the transaction

Purchase of Common Shares in GBP

c)

Price(s) and volume(s)

Price(s)	Volume(s)
£0.47	2,350

d)

Aggregated information

- Aggregated volume

- Price

n/a

n/a

e)

Date of the transaction

11/02/2026

f)

Place of the transaction

London Stock Exchange (AIM)

Notification of transactions of persons discharging managerial responsibility or connected persons

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Gareth Kaminski-Cook

2

Reason for the notification

a)

Position/status

Non-Executive Chairman

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

MYCELX Technologies Corporation

b)

LEI

213800UJZINIK2VD1G48

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Common shares of US$0.025

ISIN: US62847T2024

b)

Nature of the transaction

Purchase of Common Shares in GBP

c)

Price(s) and volume(s)

Price(s)	Volume(s)
£0.46	2,100

d)

Aggregated information

- Aggregated volume

- Price

n/a

n/a

e)

Date of the transaction

12/02/2026

f)

Place of the transaction

London Stock Exchange (AIM)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFVIFEIRLIR